Literature DB >> 7358404

Partial lipodystrophy and familial C3 deficiency.

R H McLean, D Hoefnagel.   

Abstract

A familial deficiency of C3 in the family of a patient with partial lipodystrophy is reported for the first time. This genetic defect is termed hypomorphism of C3 fast (C3f). The defect is detected by analysis of C3 phenotype by densitometry and crossed gel-immunoelectrophoresis; all affected individuals have had reduced serum C3 (lower than 2 SD below mean) on at least one occasion. The possibility that partial lipodystrophy and the frequently associated glomerulonephritis occur in immunologically deficient individuals is supported by this observation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7358404     DOI: 10.1159/000153119

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  6 in total

Review 1.  Lipoatrophic diabetes and other related syndromes.

Authors:  Elif Arioglu Oral
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

Review 2.  The role of complement system in adipose tissue-related inflammation.

Authors:  Sonia I Vlaicu; Alexandru Tatomir; Dallas Boodhoo; Stefan Vesa; Petru A Mircea; Horea Rus
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

Review 3.  Dysmorphic syndromes with demonstrable biochemical abnormalities.

Authors:  P T Clayton; E Thompson
Journal:  J Med Genet       Date:  1988-07       Impact factor: 6.318

4.  Partial lipodystrophy and renal disease.

Authors:  J Cahill; S Waldron; G O'Neill; B S Duffy
Journal:  Ir J Med Sci       Date:  1983-12       Impact factor: 1.568

Review 5.  Biomarkers of obesity and subsequent cardiovascular events.

Authors:  Salma Musaad; Erin N Haynes
Journal:  Epidemiol Rev       Date:  2007-05-10       Impact factor: 6.222

6.  C5a receptor deficiency alters energy utilization and fat storage.

Authors:  Christian Roy; Abhishek Gupta; Alexandre Fisette; Marc Lapointe; Pegah Poursharifi; Denis Richard; Huiling Lu; Bao Lu; Norma Gerard; Craig Gerard; Katherine Cianflone
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.